PA
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



1. Report Shows Shift in Starting Salaries for Physicians
2. Recommendations on the use of 18F-FDG PET in oncology
3. Use of Antiemetic Agents in Acute Gastroenteritis
4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer
5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Do statins reduce hepatitis C RNA titers during routine clinical use
World Journal of Gastroenterology, 10/30/09

Forde KA et al. – There was no apparent effect of statins on HCV viral replication in this analysis. Further investigation is warranted to explore the possible antiviral properties of triglyceride–lowering agents and their potential role as adjuncts to standard HCV therapy.

Related Articles

De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation
Liver Transplantation, 10/30/09    Relevance Score: 70%

Treatment modalities for hypersplenism in liver transplant recipients with recurrent hepatitis C
World Journal of Gastroenterology, 10/30/09    Relevance Score: 70%

FOXP3 Expression in Hepatitis C Virus-Specific CD4+ T Cells During Acute Hepatitis C
Gastroenterology, 10/06/09    Relevance Score: 70%

Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial
Hepatology, 10/14/09    Relevance Score: 69%

The HLA-ER/HLA-ER Genotype Affects the Natural Course of Hepatitis C Virus (HCV) Infection and Is Associated with HLA-E–Restricted Recognition of an HCV-Derived Peptide by Interferon[gamma]–Secreting Human CD8+ T Cells
The Journal of Infectious Diseases, 10/14/09    Relevance Score: 69%

Today in Gastroenterology...keeping you current

Laparoscopic adjustable gastric banding
Australian Family Physician, 12/09/09

Irritable bowel syndrome - The role of complementary medicines in treatment
Australian Family Physician, 12/09/09

Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis
Gastroenterology, 12/09/09

 See all of Gastroenterology

Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address